EudraLex

EudraLex

EudraLex is the collection of rules and regulations governing medicinal products in the European Union.

Volumes

EudraLex consists of 10 volumes:
*Concerning Medicinal Products for Human use:
**Volume 1 - Pharmaceutical Legislation.
**Volume 2 - Notice to Applicants.
***Volume 2A deals with procedures for marketing authorisation.
***Volume 2B deals with the presentation and content of the application dossier.
***Volume 2C deals with Guidelines.
**Volume 3 - Guidelines.

*Concerning Medicinal Products for human use in clinical trials (investigational medicinal products).
**Volume 10 - Clinical trials.

*Concerning Veterinary Medicinal Products:
**Volume 5 - Pharmaceutical Legislation.
**Volume 6 - Notice to Applicants.
**Volume 7 - Guidelines.
**Volume 8 - Maximum residue limits.
*Concerning Medicinal Products for Human and Veterinary use:
**Volume 4 - Good Manufacturing Practices.
**Volume 9 - Pharmacovigilance.

*Miscellaneous:
**Guidelines on Good Distribution Practice of Medicinal Products for Human Use (94/C 63/03)

Directives

*Directive 65/65/EEC1
*Directive 75/318/EEC
*Directive 75/319/EEC
*Directive 93/41/EEC
*Directive 2001/20/EC
*Directive 2001/83/EC
*Directive 2005/28/EC

ee also

*European Union law
*European Union directive
*European Commission
*Directorate-General
*EUR-Lex
*Regulatory requirement
*Regulation of therapeutic goods
*International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use
*Good clinical practice
*European Medicines Agency
*EUDRANET
*EudraVigilance
*Title 21 of the Code of Federal Regulations (USA)
*Drug development

References

* Eudralex,The Rules Governing Medicinal Products in the European Union, European Communities Commission. Directorate-General for Industry, Pharmaceuticals and Cosmetics.
** Vol. 1: Pharmaceutical legislation: medicinal products for human use. ISBN 9282820327
** Vol. 2: Notice to applicants: medicinal products for human use. ISBN 011975780X
** Vol. 3: Guidelines: medicinal products for human use. ISBN 9282824365
** Vol. 4: Good manufacturing practices: medicinal products for human and veterinary use. ISBN 9282820297
** Vol. 5: Pharmaceutical legislation: veterinary medicinal products. ISBN 9282820378
** Vol. 6: Notice to applicants: veterinary medical products. ISBN 0119853515
** Vol. 7. Guidelines: Veterinary medicinal products. ISBN 0119853663
* Markus Hartmann and Florence Hartmann-Vareilles, "The Clinical Trials Directive: How Is It Affecting Europe's Noncommercial Research?", PLoS Clin Trials. 2006 June; 1(2): e13

External links

* [http://ec.europa.eu/enterprise/pharmaceuticals/index_en.htm News on Pharmaceuticals] , (European Union)
* [http://ec.europa.eu/enterprise/pharmaceuticals/eudralex/ EudraLex]
* [http://eur-lex.europa.eu/en/index.htm EUR-Lex]
* [http://ec.europa.eu/enterprise/pharmaceuticals/review/index.htm Review of pharmaceutical legislation] (EU DG Enterprise and Industry)
* [http://ec.europa.eu/enterprise/index_en.htm Directorate General Enterprise and Industry] (European Commission)


Wikimedia Foundation. 2010.

Игры ⚽ Поможем написать реферат

Look at other dictionaries:

  • Arzneimittelzulassung (EU) — Die Arzneimittelzulassung ist eine behördlich erteilte Genehmigung, die erforderlich ist, um ein industriell hergestelltes, verwendungsfertiges Arzneimittel anbieten, vertreiben oder abgeben zu können. Der Zweck eines solchen Zulassungsverfahrens …   Deutsch Wikipedia

  • Concerned Member State — Die Arzneimittelzulassung ist eine behördlich erteilte Genehmigung, die erforderlich ist, um ein industriell hergestelltes, verwendungsfertiges Arzneimittel anbieten, vertreiben oder abgeben zu können. Der Zweck eines solchen Zulassungsverfahrens …   Deutsch Wikipedia

  • Medikamentenzulassung — Die Arzneimittelzulassung ist eine behördlich erteilte Genehmigung, die erforderlich ist, um ein industriell hergestelltes, verwendungsfertiges Arzneimittel anbieten, vertreiben oder abgeben zu können. Der Zweck eines solchen Zulassungsverfahrens …   Deutsch Wikipedia

  • Nutzen-Risiko-Verhältnis — Die Arzneimittelzulassung ist eine behördlich erteilte Genehmigung, die erforderlich ist, um ein industriell hergestelltes, verwendungsfertiges Arzneimittel anbieten, vertreiben oder abgeben zu können. Der Zweck eines solchen Zulassungsverfahrens …   Deutsch Wikipedia

  • Regulatory requirement — Regulatory requirements are part of the process of drug discovery and drug development. Regulatory requirements describe what is necessary for a new drug to be approved for marketing in any particular country. In the US, it is the function of the …   Wikipedia

  • Generic drug — A generic drug (generic drugs, short: generics) is a drug defined as a drug product that is comparable to brand/reference listed drug product in dosage form, strength, route of administration, quality and performance characteristics, and intended …   Wikipedia

  • European Medicines Agency — European Medicines Agency …   Wikipedia

  • Qualified Person — (QP) is a technical term used in European Union pharmaceutical regulation (Directive 2001/83/EC for Medicinal products for human use). The regulations specify that no batch of medicinal product can be released for sale or supply prior to… …   Wikipedia

  • Electronic Common Technical Document — The electronic Common Technical Document (eCTD) is an interface for the pharmaceutical industry to agency transfer of regulatory information.The content is based on the Common Technical Document (CTD) format.It was developed by the International… …   Wikipedia

  • Directive 2001/83/EC — of the European Parliament and of the Council of 6 November 2001 on the Community code relating to medicinal products for human use. The Directive dealt with the disparities between certain nationalprovisions, in particular between provisions… …   Wikipedia

Share the article and excerpts

Direct link
… Do a right-click on the link above
and select “Copy Link”